ブース番号4U-24
カテゴリー原料

Mithra Biotechnology Inc.

小間番号:4U-24
カテゴリー:原料
企業情報
Email: yrchen@mithracro.com TEL: +886-2-2696-2669 住所: 7F, No.104, Sec.1, Xintai 5th Rd., Xizhi Dist., New Taipei City 221411, Taiwan R.O.C. URL: http://www.mithracro.com
日本におけるコンタクト先
代理店名: LibraMedicina Inc. Email: imanishi@lmed.co.jp TEL: +81-3-6712-7668 住所: Nihonbashi Life Science Bldg. No. 2, Room 704 3-11-5, Nihonbashi-honcho, Chuo-ku, Tokyo 103-0023, Japan
Mithra Biotechnology, the first CRO in Taiwan, offers integrated and multi-dimensional CRO services including bioanalytical services for chemical drugs and biologics, full characterization plans for biologics, bioavailability/bioequivalence (BA/BE) studies, and early phase clinical trials to facilitate pharmaceutical development. The company has proven expertise and experience in meeting international standards to serve the fast growing pharmaceutical industry.

企業情報

住所 7F, No.104, Sec.1, Xintai 5th Rd., Xizhi Dist., New Taipei City 221411, Taiwan R.O.C.
TEL +886-2-2696-2669
FAX +886-2-2696-2543
URL http://www.mithracro.com
Email yrchen@mithracro.com
出展品目 Bioavailability & Bioequivalence Study
Clinical Trials
Biopharmaceutical Analysis
Preclinical & Clinical Bioanalysis
Clinical Site Management
Pharmacokinetics Study
Phase I - First in Human Clinical Study
Clinical Operation
Non-NCE Drug Development-505(b)(2) pathway
Food Effect Study / Drug-Drug-Interaction
PK/PD Modeling
Lab Manual/Lab Kit Development
Immunogenicity Assessment
Biomarker Analysis
Cytokine Analysis
Antibody Drug Conjugate (ADC) Analysis
Biosimilar Development
Protein Characterization
API Analysis
Impurity Analysis

日本におけるコンタクト先

代理店名 LibraMedicina Inc.
住所 Nihonbashi Life Science Bldg. No. 2, Room 704 3-11-5, Nihonbashi-honcho, Chuo-ku, Tokyo 103-0023, Japan
TEL +81-3-6712-7668
FAX +81-3-6712-7669
Email imanishi@lmed.co.jp

出展製品・サービス

Bioavailability & Bioequivalence StudyClinical TrialsBiopharmaceutical AnalysisPreclinical & Clinical BioanalysisClinical Site ManagementPharmacokinetics StudyPhase I - First in Human Clinical StudyClinical OperationNon-NCE Drug Development-505(b)(2) pathwayFood Effect Study / Drug-Drug-InteractionPK/PD ModelingLab Manual/Lab Kit DevelopmentImmunogenicity AssessmentBiomarker AnalysisCytokine AnalysisAntibody Drug Conjugate (ADC) AnalysisBiosimilar DevelopmentProtein CharacterizationAPI AnalysisImpurity Analysis